Literature DB >> 28078184

Precision medicine and molecular imaging: new targeted approaches toward cancer therapeutic and diagnosis.

Mojtaba Ghasemi1, Iraj Nabipour2, Abdolmajid Omrani3, Zeinab Alipour3, Majid Assadi4.   

Abstract

This paper presents a review of the importance and role of precision medicine and molecular imaging technologies in cancer diagnosis with therapeutics and diagnostics purposes. Precision medicine is progressively becoming a hot topic in all disciplines related to biomedical investigation and has the capacity to become the paradigm for clinical practice. The future of medicine lies in early diagnosis and individually appropriate treatments, a concept that has been named precision medicine, i.e. delivering the right treatment to the right patient at the right time. Molecular imaging is quickly being recognized as a tool with the potential to ameliorate every aspect of cancer treatment. On the other hand, emerging high-throughput technologies such as omics techniques and systems approaches have generated a paradigm shift for biological systems in advanced life science research. In this review, we describe the precision medicine, difference between precision medicine and personalized medicine, precision medicine initiative, systems biology/medicine approaches (such as genomics, radiogenomics, transcriptomics, proteomics, and metabolomics), P4 medicine, relationship between systems biology/medicine approaches and precision medicine, and molecular imaging modalities and their utility in cancer treatment and diagnosis. Accordingly, the precision medicine and molecular imaging will enable us to accelerate and improve cancer management in future medicine.

Entities:  

Keywords:  P4 medicine; Precision medicine; cancer theranostics; metabolomics-based systems medicine; molecular imaging; precision medicine initiative; radio-omics; systems biology

Year:  2016        PMID: 28078184      PMCID: PMC5218860     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  94 in total

Review 1.  Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine.

Authors:  Andrea D Weston; Leroy Hood
Journal:  J Proteome Res       Date:  2004 Mar-Apr       Impact factor: 4.466

Review 2.  Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials?

Authors:  Jan van der Greef; Thomas Hankemeier; Robert N McBurney
Journal:  Pharmacogenomics       Date:  2006-10       Impact factor: 2.533

Review 3.  A review of NIR dyes in cancer targeting and imaging.

Authors:  Shenglin Luo; Erlong Zhang; Yongping Su; Tianmin Cheng; Chunmeng Shi
Journal:  Biomaterials       Date:  2011-07-02       Impact factor: 12.479

4.  Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B.

Authors:  William R Wikoff; Samir Hanash; Brian DeFelice; Suzanne Miyamoto; Matt Barnett; Yang Zhao; Gary Goodman; Ziding Feng; David Gandara; Oliver Fiehn; Ayumu Taguchi
Journal:  J Clin Oncol       Date:  2015-08-17       Impact factor: 44.544

Review 5.  Preclinical magnetic resonance imaging and systems biology in cancer research: current applications and challenges.

Authors:  Chris Albanese; Olga C Rodriguez; John VanMeter; Stanley T Fricke; Brian R Rood; YiChien Lee; Sean S Wang; Subha Madhavan; Yuriy Gusev; Emanuel F Petricoin; Yue Wang
Journal:  Am J Pathol       Date:  2012-12-04       Impact factor: 4.307

Review 6.  Molecular imaging for cancer diagnosis and surgery.

Authors:  Timon Hussain; Quyen T Nguyen
Journal:  Adv Drug Deliv Rev       Date:  2013-09-22       Impact factor: 15.470

Review 7.  RNA-Seq: a revolutionary tool for transcriptomics.

Authors:  Zhong Wang; Mark Gerstein; Michael Snyder
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

Review 8.  [Gastroenterological Cancer Diagnosis by Metabolomics-Discovery of Pancreatic Cancer Biomarker].

Authors:  Masaru Yoshida; Shin Nishiumi; Takeshi Azuma
Journal:  Rinsho Byori       Date:  2015-04

9.  Systems biology: the next frontier for bioinformatics.

Authors:  Vladimir A Likić; Malcolm J McConville; Trevor Lithgow; Antony Bacic
Journal:  Adv Bioinformatics       Date:  2011-02-09

Review 10.  Systems biology in the context of big data and networks.

Authors:  Md Altaf-Ul-Amin; Farit Mochamad Afendi; Samuel Kuria Kiboi; Shigehiko Kanaya
Journal:  Biomed Res Int       Date:  2014-05-27       Impact factor: 3.411

View more
  25 in total

Review 1.  PET and SPECT imaging of melanoma: the state of the art.

Authors:  Weijun Wei; Emily B Ehlerding; Xiaoli Lan; Quanyong Luo; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-10-30       Impact factor: 9.236

2.  Decorated Superparamagnetic Iron Oxide Nanoparticles with Monoclonal Antibody and Diethylene-Triamine-Pentaacetic Acid Labeled with Thechnetium-99m and Galium-68 for Breast Cancer Imaging.

Authors:  Marta de Souza Albernaz; Sergio Hiroshi Toma; Jeff Clanton; Koiti Araki; Ralph Santos-Oliveira
Journal:  Pharm Res       Date:  2018-01-05       Impact factor: 4.200

3.  Metabolomics technology and bioinformatics for precision medicine.

Authors:  Rajeev K Azad; Vladimir Shulaev
Journal:  Brief Bioinform       Date:  2019-11-27       Impact factor: 11.622

Review 4.  Molecular imaging of β-cells: diabetes and beyond.

Authors:  Weijun Wei; Emily B Ehlerding; Xiaoli Lan; Quan-Yong Luo; Weibo Cai
Journal:  Adv Drug Deliv Rev       Date:  2018-07-03       Impact factor: 15.470

5.  Theranostics: is it really a revolution? Evaluating a new term in medicine.

Authors:  Urban Wiesing
Journal:  Med Health Care Philos       Date:  2019-12

6.  The need for standardization of nuclear cardiology reporting and data system (NCAD-RADS): Learning from coronary artery disease (CAD), breast imaging (BI), liver imaging (LI), and prostate imaging (PI) RADS.

Authors:  Majid Assadi; Erik Velez; Mohammad Hosein Najafi; Ali Gholamrezanezhad
Journal:  J Nucl Cardiol       Date:  2018-10-29       Impact factor: 5.952

7.  An aggressive functioning pituitary adenoma treated with peptide receptor radionuclide therapy.

Authors:  Majid Assadi; Reza Nemati; Hossein Shooli; Seyed Javad Rekabpour; Iraj Nabipour; Esmail Jafari; Ali Gholamrezanezhad; Abdullatif Amini; Hojjat Ahmadzadehfar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-18       Impact factor: 9.236

8.  Standardized uptake value (SUVmax) in 18F-FDG PET/CT is correlated with the total number of main oncogenic anomalies in cancer patients.

Authors:  Amin Haghighat Jahromi; Geraldine Chang; Razelle Kurzrock; Carl K Hoh
Journal:  Cancer Biol Ther       Date:  2020-11-01       Impact factor: 4.742

Review 9.  ECRG4: a new potential target in precision medicine.

Authors:  Xin Qin; Ping Zhang
Journal:  Front Med       Date:  2018-07-12       Impact factor: 4.592

Review 10.  An update on PET-based molecular imaging in neuro-oncology: challenges and implementation for a precision medicine approach in cancer care.

Authors:  Hossein Shooli; Habibollah Dadgar; Yì-Xiáng J Wáng; Manochehr Seyedi Vafaee; Saman Rassaei Kashuk; Reza Nemati; Esmail Jafari; Iraj Nabipour; Ali Gholamrezanezhad; Majid Assadi; Mykol Larvie
Journal:  Quant Imaging Med Surg       Date:  2019-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.